February 23, 2009
Pioneer Surgical Technology Wins Frost & Sullivan Innovation Award
Novel Bone Graft Substitute Now Available in the U.S.
Marquette, MI and Greenville, NC - Pioneer Surgical Technology, Inc., a leading innovator in the design and manufacture of spinal and orthopaedic implants, instruments and biologic products, announced that it has won the prestigious Frost & Sullivan 2009 North American Technology Innovation of the Year Award for the E-Matrix Tissue Scaffold, recently launched in the United States.
The patented E-Matrix technology provides a bioscaffold for leading edge biologic products in orthopaedics and other therapeutic areas. Pioneer's CEO and President, Jeff Millin, noted, "This award reflects Pioneer's commitment to deliver on innovation that benefits patients and surgeons, and is cost-effective for the healthcare system." E-Matrix is the result of over ten years of dedicated research and development.
Ronald S. Hill, PhD, Vice President of Research and Development, says, "Frost & Sullivan is world renowned for technology analysis and after an exhaustive review of products in this therapeutic category, Pioneer has been recognized for the significance and potential of this innovative technology to become the market leader."
Pioneer continues to focus on commercializing these novel technologies and recently launched a bone graft substitute to the US orthopaedic market utilizing the E-Matrix bioscaffold combined with nanOss, a proprietary nano-crystalline hydroxyapatite.
About Pioneer Surgical Technology
Pioneer Surgical Technology, Inc., headquartered in Marquette, Michigan, with Biologic R&D and manufacturing facilities in North Carolina and Massachusetts, is a dynamic medical device firm with a full line of motion preservation devices available commercially in Europe or under clinical evaluation in the U.S., in addition to diverse spinal fusion systems and advanced biologics. Pioneer's signature articulating P3 Technology -- Pioneer PEEK-on-PEEK, is key to the leading nucleus replacement system NuBac currently in U.S. clinical trials. Pioneer's focus on innovation has resulted in over 100 U.S. and foreign patents with numerous patents pending. Pioneer focuses on developing products which are easier and faster for the surgeon, cost effective for the health care system, and provide better patient outcomes.
RSS